Martin Hoyle

Professor

  • 1235 Citations
  • 21 h-Index
20042022
If you made any changes in Pure these will be visible here soon.

Research Outputs 2004 2019

  • 1235 Citations
  • 21 h-Index
  • 47 Article
  • 19 Commissioned report
  • 1 Other report
  • 1 Review article
Filter
Review article
2017

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation

Huxley, N., Crathorne, L., Varley-Campbell, J., Tikhonova, I., Snowsill, T., Briscoe, S., Peters, J., Bond, M., Napier, M. & Hoyle, M., Jun 2017, In : Health Technology Assessment. 21, 38, p. 1-294 294 p.

Research output: Contribution to journalReview articleResearchpeer-review

Open Access
File
irinotecan
oxaliplatin
Leucovorin
Fluorouracil
Cost-Benefit Analysis